According to Zentalis Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is -167,343.00%. At the end of 2018 the company had an Operating Margin of -167,342.86%.
Year | Operating Margin | Change |
---|---|---|
2018 | -167,342.86% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
![]() | -8,391.15% | -94.99% | ๐บ๐ธ USA |
![]() | -1.45% | -100.00% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.